ECHS1 and viral infectious disease: ECHS1 mutations lead to decreased fatty acid mitochondrial β-oxidation activity, thereby reducing the formation of important energy substrates (such as acetyl CoA), reducing the production of ATP, leading to energy deficiency in the catabolic state (such as fever, after viral infection), and increasing organs.